Berg A, Fagervoll R, Aulie Michelet A, Dugstad H
Department of Chemical Synthesis, Nycomed AS, Oslo, Norway.
Acta Radiol Suppl. 1987;370:27-31.
The process developed for the synthesis of iopentol consists of several steps. Nine possible impurities from the synthesis of iopentol have been synthesized and one has been isolated from iopentol mother liquor. These substances have been analysed by HPLC methods developed for routine control of iopentol bulk substance. Capacity factors have been calculated for each compound which relate its position in the chromatogram to iopentol. Some of the synthesized compounds have never been found in iopentol and their toxicities have therefore not been determined. Approximate intravenous LD50 values in mice have been determined for the remaining compounds. Taking into consideration these results and the small quantities in which the impurities are present, it is unlikely that they will affect the safety of the final product.
合成碘海醇所采用的工艺包括几个步骤。已合成了碘海醇合成过程中可能产生的9种杂质,其中1种是从碘海醇母液中分离得到的。这些物质已通过为碘海醇原料药常规控制而开发的HPLC方法进行了分析。已计算出每种化合物的容量因子,该因子将其在色谱图中的位置与碘海醇相关联。一些合成的化合物从未在碘海醇中被发现,因此尚未确定它们的毒性。已测定了其余化合物在小鼠体内的近似静脉注射LD50值。考虑到这些结果以及杂质的存在量很少,它们不太可能影响最终产品的安全性。